Masumoto A - Search Results

1

Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm.

Mohri M, Shimokawa H, Hirakawa Y, Masumoto A, Takeshita A. Mohri M, et al. Among authors: masumoto a. J Am Coll Cardiol. 2003 Jan 1;41(1):15-9. doi: 10.1016/s0735-1097(02)02632-3. J Am Coll Cardiol. 2003. PMID: 12570938 Free article. Clinical Trial.

2

Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina.

Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A. Masumoto A, et al. Circulation. 2002 Apr 2;105(13):1545-7. doi: 10.1161/hc1002.105938. Circulation. 2002. PMID: 11927519 Clinical Trial.

3

Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure.

Kishi T, Hirooka Y, Masumoto A, Ito K, Kimura Y, Inokuchi K, Tagawa T, Shimokawa H, Takeshita A, Sunagawa K. Kishi T, et al. Among authors: masumoto a. Circulation. 2005 May 31;111(21):2741-7. doi: 10.1161/CIRCULATIONAHA.104.510248. Circulation. 2005. PMID: 15927989 Clinical Trial.

4

Anti-ischemic effects of fasudil, a specific Rho-kinase inhibitor, in patients with stable effort angina.

Fukumoto Y, Mohri M, Inokuchi K, Ito A, Hirakawa Y, Masumoto A, Hirooka Y, Takeshita A, Shimokawa H. Fukumoto Y, et al. Among authors: masumoto a. J Cardiovasc Pharmacol. 2007 Mar;49(3):117-21. doi: 10.1097/FJC.0b013e31802ef532. J Cardiovasc Pharmacol. 2007. PMID: 17414222 Clinical Trial.

5

Three-year follow-up of the Japanese patients with microvascular angina attributable to coronary microvascular spasm.

Masumoto A, Mohri M, Takeshita A. Masumoto A, et al. Int J Cardiol. 2001 Dec;81(2-3):151-6. doi: 10.1016/s0167-5273(01)00540-x. Int J Cardiol. 2001. PMID: 11744131

6

Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans.

Masumoto A, Hirooka Y, Shimokawa H, Hironaga K, Setoguchi S, Takeshita A. Masumoto A, et al. Hypertension. 2001 Dec 1;38(6):1307-10. doi: 10.1161/hy1201.096541. Hypertension. 2001. PMID: 11751708 Clinical Trial.

7

The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study.

Fukumoto Y, Tsutsui H, Tsuchihashi M, Masumoto A, Takeshita A; Cholesterol Embolism Study(CHEST) Investigators. Fukumoto Y, et al. Among authors: masumoto a. J Am Coll Cardiol. 2003 Jul 16;42(2):211-6. doi: 10.1016/s0735-1097(03)00579-5. J Am Coll Cardiol. 2003. PMID: 12875753 Free article.

8

Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin).

Masumoto A, Hirooka Y, Hironaga K, Eshima K, Setoguchi S, Egashira K, Takeshita A. Masumoto A, et al. Am J Cardiol. 2001 Dec 1;88(11):1291-4. doi: 10.1016/s0002-9149(01)02090-2. Am J Cardiol. 2001. PMID: 11728357 Clinical Trial. No abstract available.

9

Evaluation of Coronary Artery Disease in Patients with Atrial Fibrillation by Cardiac Computed Tomography for Catheter Ablation: CADAF-CT Trial 2.

Antoku Y, Takemoto M, Mito T, Masumoto A, Nozoe M, Tanaka A, Yamamoto Y, Ueno T, Tsuchihashi T. Antoku Y, et al. Among authors: masumoto a. Intern Med. 2020 Nov 15;59(22):2831-2837. doi: 10.2169/internalmedicine.4745-20. Epub 2020 Jul 21. Intern Med. 2020. PMID: 32713911 Free PMC article.

10

Acute heart failure caused by mechanical valve leaflet dislodgment at the mitral position.

Nakamura T, Masumoto A, Tahara N, Kuroda Y, Fukumoto Y. Nakamura T, et al. Among authors: masumoto a. Eur Heart J. 2017 Mar 7;38(10):761. doi: 10.1093/eurheartj/ehw521. Eur Heart J. 2017. PMID: 28025190 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters